206 related articles for article (PubMed ID: 18624670)
21. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant Acinetobacter baumannii infections in three returning travelers evacuated from Algeria, Thailand, and Turkey after hospitalization in local intensive care units.
Hussenet C; Jauréguiberry S; Robert J; Rouby JJ; Bricaire F; Caumes E
J Travel Med; 2011; 18(5):358-60. PubMed ID: 21896102
[TBL] [Abstract][Full Text] [Related]
23. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Mar; 35(3):219-26. PubMed ID: 20047818
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic resistance determinants of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria.
Bakour S; Touati A; Sahli F; Ameur AA; Haouchine D; Rolain JM
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):529-31. PubMed ID: 23688522
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
26. Acinetobacter baumannii resistant to everything: what should we do?
Vila J; Pachón J
Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
[No Abstract] [Full Text] [Related]
27. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
28. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
29. Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.
López-Rojas R; Smani Y; Pachón J
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):231-3. PubMed ID: 23458763
[No Abstract] [Full Text] [Related]
30. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria.
Touati M; Diene SM; Racherache A; Dekhil M; Djahoudi A; Rolain JM
Int J Antimicrob Agents; 2012 Jul; 40(1):89-91. PubMed ID: 22580030
[No Abstract] [Full Text] [Related]
31. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
Katragkou A; Roilides E
J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
[No Abstract] [Full Text] [Related]
32. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
[TBL] [Abstract][Full Text] [Related]
33. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
Kiratisin P; Apisarnthanarak A; Kaewdaeng S
Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913
[TBL] [Abstract][Full Text] [Related]
34. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
[TBL] [Abstract][Full Text] [Related]
35. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
[TBL] [Abstract][Full Text] [Related]
36. Do Results of Surveillance Cultures Impact the Choice of Empirical Antibiotics Among Patients with Carbapenem-Resistant Acinetobacter baumannii Infections?
Rosa R; Castro J; Latibeaudiere R; Namias N; Munoz-Price LS
Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1455-7. PubMed ID: 26353941
[TBL] [Abstract][Full Text] [Related]
37. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K
J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
[TBL] [Abstract][Full Text] [Related]
39. Patterns of resolution of infectious parameters in multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia.
Myrianthefs P; Ioannides K; Gavala A; Evodia E; Tsakris A; Baltopoulos G
J Hosp Infect; 2010 May; 75(1):79-80. PubMed ID: 20303615
[No Abstract] [Full Text] [Related]
40. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
Motaouakkil S; Charra B; Hachimi A; Benslama A
Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
